Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$307M |
| 2 |
Vanguard Morningstar Value ETF
VTV
|
+$294M |
| 3 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$246M |
| 4 |
Costco
COST
|
+$225M |
| 5 |
Lyft
LYFT
|
+$223M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ferguson
FERG
|
+$692M |
| 2 |
Linde
LIN
|
+$624M |
| 3 |
Medtronic
MDT
|
+$527M |
| 4 |
Goldman Sachs
GS
|
+$340M |
| 5 |
Microsoft
MSFT
|
+$301M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.25% |
| 2 | Healthcare | 13.3% |
| 3 | Financials | 12.53% |
| 4 | Consumer Discretionary | 10.81% |
| 5 | Communication Services | 8.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2026
Telkom Indonesia
TLK
$14.6B
| $12.1M | ﹤0.01% |
557,995
+14,923
| +3% | +$345K |
|
2027
OFG Bancorp
OFG
$2.28B
| $12.1M | ﹤0.01% |
546,212
-38,291
| -7% | -$910K |
|
2028
Donnelley Financial Solutions
DFIN
$1.2B
| $12.1M | ﹤0.01% |
365,691
+39,166
| +12% | +$1.17M |
|
2029
Teck Resources
TECK
$31.2B
| $12.1M | ﹤0.01% |
523,336
-23,034
| -4% | -$524K |
|
2030
Helios Technologies
HLIO
$2.69B
| $12M | ﹤0.01% |
154,053
-4,492
| -3% | -$329K |
|
2031
The Bancorp
TBBK
$2.84B
| $12M | ﹤0.01% |
521,808
+259,067
| +99% | +$6.08M |
|
2032
CorVel
CRVL
$3.32B
| $12M | ﹤0.01% |
267,114
-31,497
| -11% | -$1.24M |
|
2033
John B. Sanfilippo & Son
JBSS
$1.01B
| $11.9M | ﹤0.01% |
134,824
+175
| +0.1% | +$15.9K |
|
2034
Smith & Wesson
SWBI
$643M
| $11.9M | ﹤0.01% |
343,901
-48,730
| -12% | -$1.02M |
|
2035
James River Group Holdings
JRVR
$193M
| $11.9M | ﹤0.01% |
316,941
+21,071
| +7% | +$842K |
|
2036
Kodiak Sciences
KOD
$2.59B
| $11.9M | ﹤0.01% |
127,552
+3,379
| +3% | +$324K |
|
2037
Bloom Energy
BE
$67.7B
| $11.8M | ﹤0.01% |
440,811
+7,094
| +2% | +$172K |
|
2038
State Street SPDR S&P 500 Fossil Fuel Reserves Free ETF
SPYX
$2.88B
| $11.8M | ﹤0.01% |
334,623
+264,000
| +374% | +$9.1M |
|
2039
Valaris
VAL
$5.95B
| $11.8M | ﹤0.01% |
+409,310
| New | +$10.3M |
|
2040
State Street Technology Select Sector SPDR ETF
XLK
$124B
| $11.8M | ﹤0.01% |
160,100
+4,370
| +3% | +$306K |
|
|
WBT
2041
DELISTED
Welbilt, Inc.
WBT
| $11.7M | ﹤0.01% |
507,527
-34,111
| -6% | -$724K |
|
2042
BioCryst Pharmaceuticals
BCRX
$2.49B
| $11.7M | ﹤0.01% |
738,313
+23,412
| +3% | +$318K |
|
2043
Pilgrim's Pride
PPC
$6.64B
| $11.7M | ﹤0.01% |
525,637
-1,663
| -0.3% | -$39.6K |
|
2044
FuboTV Inc
FUBO
$307M
| $11.6M | ﹤0.01% |
30,223
+27,486
| +1,004% | +$7.85M |
|
2045
PetMed Express
PETS
$38.9M
| $11.6M | ﹤0.01% |
365,151
-12,501
| -3% | -$397K |
|
2046
Myers Industries
MYE
$1.24B
| $11.6M | ﹤0.01% |
552,359
-1,636
| -0.3% | -$35K |
|
2047
Leslie's
LESL
$6.04M
| $11.6M | ﹤0.01% |
21,080
+8,907
| +73% | +$4.88M |
|
|
FRG
2048
DELISTED
Franchise Group, Inc.
FRG
| $11.6M | ﹤0.01% |
328,278
+3,856
| +1% | +$142K |
|
2049
AstraZeneca
AZN
$243B
| $11.6M | ﹤0.01% |
96,514
+1,636
| +2% | +$179K |
|
|
DRNA
2050
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $11.5M | ﹤0.01% |
309,303
+44,329
| +17% | +$1.36M |
|
Similar funds
Bank of New York Mellon's Q2 2021 Portfolio in Review
As of Q2 2021, Bank of New York Mellon held 4,590 positions worth $517B, up 5.6% from $489B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Bank of New York Mellon's Q2 2021 filing shows 277 new, 1,772 increased, 2,129 reduced and 201 closed positions. Its largest new stake was Organon & Co: 4,240,135 shares worth $128M. The largest sale was Ferguson, an estimated $692M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.
- Bank of New York Mellon's largest Q2 2021 buy was Organon & Co: 4,240,135 shares worth $128M.
- Bank of New York Mellon added most to Vanguard FTSE Developed Markets ETF in Q2 2021, an estimated $307M increase.
- Bank of New York Mellon's biggest Q2 2021 reduction was Ferguson, cutting an estimated $692M.
- Bank of New York Mellon fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $164M.
- Bank of New York Mellon's ten largest holdings make up 19% of its $517B portfolio in Q2 2021.
- Bank of New York Mellon opened 277 new positions and closed 201 in Q2 2021.
- Bank of New York Mellon's portfolio value rose 5.6% quarter-over-quarter to $517B.
Based on Bank of New York Mellon's 13F filing for Q2 2021, filed 11 Aug 2021.